Affiliation:
1. University of Basel: Universitat Basel
Abstract
Abstract
Background
Pragmatic trials provide decision-oriented, real-world evidence that is highly applicable and generalizable. The interest in real world evidence is fueled by the assumption that effects in the “real-world” are different to effects obtained under artificial, controlled, research conditions as often used for traditional explanatory trials. However, it is unknown which features of pragmatism, generalizability, and applicability would be responsible for such differences. There is a need to provide empirical evidence and promote meta-research to answer these fundamental questions on the pragmatism of randomized trials and real-world evidence. Here, we describe the rationale and design of the PragMeta database which pursues this goal (www.PragMeta.org).
Methods
PragMeta is a non-commercial, open data platform and infrastructure to facilitate research on pragmatic trials. It collects and shares data from published randomized trials that either have a specific design feature or other characteristic related to pragmatism or they form clusters of trials addressing the same research question but having different aspects of pragmatism. This lays the foundation to determine the relationship of various features of pragmatism, generalizability, and applicability with intervention effects or other trial characteristics.
The database contains trial data actively collected for PragMeta, but also allows to import and link existing datasets of trials collected for other purposes, forming a large-scale meta-database. PragMeta captures data on (1) trial and design characteristics (e.g., sample size, population, intervention/comparison, outcome, longitudinal structure, blinding), (2) effects estimates, and (3) various determinants of pragmatism (e.g., the use of routinely collected data) and ratings from established tools used to determine pragmatism (e.g., the PRragmatic–Explanatory Continuum Indicator Summary 2; PRECIS-2).
PragMeta is continuously provided online, inviting the meta-research community to collaborate, contribute, and/or use the database. As of January 25, 2023, PragMeta contains data from >400 trials with assessments on pragmatism.
Conclusions
PragMeta will inform a better understanding of pragmatism and the generation and interpretation of real-world evidence.
Publisher
Research Square Platform LLC
Reference25 articles.
1. Explanatory and pragmatic attitudes in therapeutical trials;Schwartz D;J Clin Epidemiol,2009
2. GetReal Initiative. GetReal Trial Tool: Navigating RWE options in clinical trials. 2022. https://getrealtrialtool.eu/. Accessed 21 Nov 2022.
3. GetReal Initiative. PragMagic: Pragmatic trial resources. https://www.pragmagic.eu/. Accessed 21 Nov 2022.
4. National Institutes of Health. Rethinking Clinical Trials: A Living Textbook of Pragmatic Clinical Trials. 2022. https://rethinkingclinicaltrials.org/. Accessed 21 Nov 2022.
5. The PRECIS-2 tool: designing trials that are fit for purpose;Loudon K;BMJ,2015